US Withdraws Pancreatic Cancer Study by Barbacid Due to Conflict of Interest

A study on pancreatic cancer by Barbacid and two co-authors has been withdrawn by a US academy due to a conflict of interest. The researchers reportedly have financial interests in Vega Oncotargets, a company established to develop therapies for this type of cancer.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

la-vanguardiaSpanish126d ago

EEUU retira el estudio de Barbacid sobre cáncer de páncreas por conflicto de intereses

Según la academia, Barbacid y dos de las coautoras del trabajo tienen intereses financieros en Vega Oncotargets, que se creó con el objetivo de desarrollar terapias contra este tipo de cáncer

Read full article →

US Withdraws Pancreatic Cancer Study by Barbacid Due to Conflict of Interest

Sources

EEUU retira el estudio de Barbacid sobre cáncer de páncreas por conflicto de intereses

Related Stories

BOJ to debate rate rise, inflation much closer to 2% target: governor

Markets React to Middle East Tensions as Oil Prices Surge and Gold Falls

Apple Announces Executive Compensation Packages for Ternus and Cook

Bessent Urges BOJ Chief to Take Decisive Action to Stabilize Yen